|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 274.80 ILa | -1.51% |
|
-2.83% | -50.12% |
| 06-17 | Matricelf Completes GLP Safety Study for Engineered Neural Tissue Implant | CI |
| 03-30 | Matricelf Ltd. Enters into Collaborative Research Agreement with CiRA Foundation | CI |
Company Valuation: Matricelf Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Market Cap 1 | 103.8 | 54 | 50.14 | 59.23 | 151.9 |
| Change | - | -47.98% | -7.15% | 18.14% | 156.5% |
| Enterprise Value (EV) 1 | 82.91 | 54 | 28.05 | 48.55 | 131.8 |
| Change | - | -34.87% | -48.06% | 73.11% | 171.45% |
| P/E | -4.58x | -4.69x | -4.66x | -3.74x | -3.65x |
| PBR | 3.96x | - | 2.46x | 3.91x | 15.1x |
| PEG | -0x | 0.1x | 0.72x | -0.4x | -0.1x |
| Capitalization / Revenue | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - |
| EV / EBITDA | -5.24x | -4.45x | -1.97x | -3.13x | -7.44x |
| EV / EBIT | -5.16x | -4.29x | -1.91x | -3.01x | -7.19x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -1.877 | -0.9514 | -0.89 | -0.9812 | -1.51 |
| Distribution rate | - | - | - | - | - |
| Net sales | - | - | - | - | - |
| EBITDA 1 | -15.82 | -12.13 | -14.2 | -15.52 | -17.72 |
| EBIT 1 | -16.07 | -12.59 | -14.71 | -16.11 | -18.33 |
| Net income 1 | -16.34 | -12.49 | -13.83 | -15.58 | -27.82 |
| Net Debt 1 | -20.88 | - | -22.09 | -10.68 | -20.14 |
| Reference price 2 | 8.604 | 4.462 | 4.143 | 3.666 | 5.509 |
| Nbr of stocks (in thousands) | 12,064 | 12,102 | 12,102 | 16,158 | 27,580 |
| Announcement Date | 15/03/22 | 23/02/25 | 23/02/25 | 23/02/25 | 24/03/26 |
1ILS in Million2ILS
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 27.76M | |
| 29.68x | 5.27x | 16.32x | 1.11% | 42.75B | |
| -20.5x | 304.3x | -18.74x | -.--% | 34.65B | |
| 40.3x | 4.01x | 25.68x | -.--% | 30.03B | |
| 20.41x | 2.41x | 10.42x | -.--% | 28B | |
| 29.23x | 7.56x | 19.44x | 0.43% | 24.83B | |
| 27x | 4.32x | 19.66x | -.--% | 13.14B | |
| 21.84x | 1.9x | 8.36x | 1.22% | 12.61B | |
| -20.52x | 13.52x | -20.12x | -.--% | 12.25B | |
| Average | 15.93x | 42.91x | 7.63x | 0.34% | 22.03B | |
| Weighted average by Cap. | 17.38x | 57.45x | 8.63x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MTLF Stock
- Valuation Matricelf Ltd
Select your edition
All financial news and data tailored to specific country editions
